These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

357 related articles for article (PubMed ID: 21987816)

  • 1. Cardiac myocyte follistatin-like 1 functions to attenuate hypertrophy following pressure overload.
    Shimano M; Ouchi N; Nakamura K; van Wijk B; Ohashi K; Asaumi Y; Higuchi A; Pimentel DR; Sam F; Murohara T; van den Hoff MJ; Walsh K
    Proc Natl Acad Sci U S A; 2011 Oct; 108(43):E899-906. PubMed ID: 21987816
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cardiac myocyte-specific ablation of follistatin-like 3 attenuates stress-induced myocardial hypertrophy.
    Shimano M; Ouchi N; Nakamura K; Oshima Y; Higuchi A; Pimentel DR; Panse KD; Lara-Pezzi E; Lee SJ; Sam F; Walsh K
    J Biol Chem; 2011 Mar; 286(11):9840-8. PubMed ID: 21245136
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardiac myocyte-derived follistatin-like 1 prevents renal injury in a subtotal nephrectomy model.
    Hayakawa S; Ohashi K; Shibata R; Kataoka Y; Miyabe M; Enomoto T; Joki Y; Shimizu Y; Kambara T; Uemura Y; Yuasa D; Ogawa H; Matsuo K; Hiramatsu-Ito M; van den Hoff MJ; Walsh K; Murohara T; Ouchi N
    J Am Soc Nephrol; 2015 Mar; 26(3):636-46. PubMed ID: 25071081
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Follistatin-like 1 is an Akt-regulated cardioprotective factor that is secreted by the heart.
    Oshima Y; Ouchi N; Sato K; Izumiya Y; Pimentel DR; Walsh K
    Circulation; 2008 Jun; 117(24):3099-108. PubMed ID: 18519848
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adiponectin deficiency exacerbates cardiac dysfunction following pressure overload through disruption of an AMPK-dependent angiogenic response.
    Shimano M; Ouchi N; Shibata R; Ohashi K; Pimentel DR; Murohara T; Walsh K
    J Mol Cell Cardiol; 2010 Aug; 49(2):210-20. PubMed ID: 20206634
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ablation of biglycan attenuates cardiac hypertrophy and fibrosis after left ventricular pressure overload.
    Beetz N; Rommel C; Schnick T; Neumann E; Lother A; Monroy-Ordonez EB; Zeeb M; Preissl S; Gilsbach R; Melchior-Becker A; Rylski B; Stoll M; Schaefer L; Beyersdorf F; Stiller B; Hein L
    J Mol Cell Cardiol; 2016 Dec; 101():145-155. PubMed ID: 27789290
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mixed lineage kinase-3 prevents cardiac dysfunction and structural remodeling with pressure overload.
    Calamaras TD; Baumgartner RA; Aronovitz MJ; McLaughlin AL; Tam K; Richards DA; Cooper CW; Li N; Baur WE; Qiao X; Wang GR; Davis RJ; Kapur NK; Karas RH; Blanton RM
    Am J Physiol Heart Circ Physiol; 2019 Jan; 316(1):H145-H159. PubMed ID: 30362822
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Caspase recruitment domain 6 protects against cardiac hypertrophy in response to pressure overload.
    Li L; Chen W; Zhu Y; Wang X; Jiang DS; Huang F; Wang L; Xiang F; Qin W; Wang Q; Zhang R; Zhu X; Li H; Chen X
    Hypertension; 2014 Jul; 64(1):94-102. PubMed ID: 24777975
    [TBL] [Abstract][Full Text] [Related]  

  • 9. AMP activated protein kinase-alpha2 deficiency exacerbates pressure-overload-induced left ventricular hypertrophy and dysfunction in mice.
    Zhang P; Hu X; Xu X; Fassett J; Zhu G; Viollet B; Xu W; Wiczer B; Bernlohr DA; Bache RJ; Chen Y
    Hypertension; 2008 Nov; 52(5):918-24. PubMed ID: 18838626
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transient activation of AMPK preceding left ventricular pressure overload reduces adverse remodeling and preserves left ventricular function.
    Nam DH; Kim E; Benham A; Park HK; Soibam B; Taffet GE; Kaelber JT; Suh JH; Taegtmeyer H; Entman ML; Reineke EL
    FASEB J; 2019 Jan; 33(1):711-721. PubMed ID: 30024790
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Polydatin attenuates cardiac hypertrophy through modulation of cardiac Ca2+ handling and calcineurin-NFAT signaling pathway.
    Ding W; Dong M; Deng J; Yan D; Liu Y; Xu T; Liu J
    Am J Physiol Heart Circ Physiol; 2014 Sep; 307(5):H792-802. PubMed ID: 25015961
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Overexpression of Ubiquitin-Specific Protease 2 (USP2) in the Heart Suppressed Pressure Overload-Induced Cardiac Remodeling.
    Xing J; Li P; Hong J; Wang M; Liu Y; Gao Y; Dong J; Gu H; Li L
    Mediators Inflamm; 2020; 2020():4121750. PubMed ID: 32963492
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The valosin-containing protein is a novel repressor of cardiomyocyte hypertrophy induced by pressure overload.
    Zhou N; Ma B; Stoll S; Hays TT; Qiu H
    Aging Cell; 2017 Oct; 16(5):1168-1179. PubMed ID: 28799247
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low-density lipoprotein receptor-related protein 6 regulates cardiomyocyte-derived paracrine signaling to ameliorate cardiac fibrosis.
    Wang X; Zou Y; Chen Z; Li Y; Pan L; Wang Y; Liu M; Yin C; Wu J; Yang C; Zhang L; Li C; Huang Z; Wang D; Qian J; Ge J; Zou Y; Gong H
    Theranostics; 2021; 11(3):1249-1268. PubMed ID: 33391533
    [No Abstract]   [Full Text] [Related]  

  • 15. Muscle-derived follistatin-like 1 functions to reduce neointimal formation after vascular injury.
    Miyabe M; Ohashi K; Shibata R; Uemura Y; Ogura Y; Yuasa D; Kambara T; Kataoka Y; Yamamoto T; Matsuo K; Joki Y; Enomoto T; Hayakawa S; Hiramatsu-Ito M; Ito M; Van Den Hoff MJ; Walsh K; Murohara T; Ouchi N
    Cardiovasc Res; 2014 Jul; 103(1):111-20. PubMed ID: 24743592
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SENP1 Protects Against Pressure Overload-Induced Cardiac Remodeling and Dysfunction Via Inhibiting STAT3 Signaling.
    Yang D; Fan D; Guo Z; Liu FY; Wang MY; An P; Yang Z; Tang QZ
    J Am Heart Assoc; 2022 Nov; 11(22):e027004. PubMed ID: 36370010
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long Non-Coding RNA Malat-1 Is Dispensable during Pressure Overload-Induced Cardiac Remodeling and Failure in Mice.
    Peters T; Hermans-Beijnsberger S; Beqqali A; Bitsch N; Nakagawa S; Prasanth KV; de Windt LJ; van Oort RJ; Heymans S; Schroen B
    PLoS One; 2016; 11(2):e0150236. PubMed ID: 26919721
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HSF1 deficiency accelerates the transition from pressure overload-induced cardiac hypertrophy to heart failure through endothelial miR-195a-3p-mediated impairment of cardiac angiogenesis.
    Wang S; Wu J; You J; Shi H; Xue X; Huang J; Xu L; Jiang G; Yuan L; Gong X; Luo H; Ge J; Cui Z; Zou Y
    J Mol Cell Cardiol; 2018 May; 118():193-207. PubMed ID: 29626503
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of endothelial autocrine NRG1/ERBB4 signaling in cardiac remodeling.
    Dugaucquier L; Feyen E; Mateiu L; Bruyns TAM; De Keulenaer GW; Segers VFM
    Am J Physiol Heart Circ Physiol; 2020 Aug; 319(2):H443-H455. PubMed ID: 32618511
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Follistatin-like 1 promotes cardiac fibroblast activation and protects the heart from rupture.
    Maruyama S; Nakamura K; Papanicolaou KN; Sano S; Shimizu I; Asaumi Y; van den Hoff MJ; Ouchi N; Recchia FA; Walsh K
    EMBO Mol Med; 2016 Aug; 8(8):949-66. PubMed ID: 27234440
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.